In this study, the investigators study the prognostic role of oxidative stress metabolism and
      iron in Acute myeloid leukemia.

Metabolism Des LAM

Iron

Acute Myeloid Leukemia

Diagnosis

Oxydative Stress

Primary goal of this study is to Evaluate the characteristics of regulatory networks of iron
      and redox balance in leukemic cells, to study the correlations between the prognosis of AML
      patients (in terms of response to induction chemotherapy and survival i) and metabolism of
      these markers. Secondary ones areto assess the impact of induction therapy on markers of
      oxidative stress and to correlate biological iron and redox metabolism with the molecular
      status of patients (eg Flt3/IDH/CEBPA/NPM...).

      Eligibility criteria are patients at diagnostic of de novo acute myeloid leukemia
      (promyelocytic excluded) aged from 18 to 100 years.

Metabolism Des LAM

About this trial

Study ID

Status

Type

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?